Proteome-wide covalent ligand discovery in native biological systems.
Proteome-wide covalent ligand discovery in native biological systems.
复制标题
DOI:
10.1038/nature18002
复制
发表时间:
2016-06-23
期刊:
影响因子:
64.8
通讯作者:
Cravatt BF
中科院分区:
文献类型:
--
作者:
Backus KM;Correia BE;Lum KM;Forli S;Horning BD;González-Páez GE;Chatterjee S;Lanning BR;Teijaro JR;Olson AJ;Wolan DW;Cravatt BF
Small molecules are powerful tools for investigating protein function and can serve as leads for new therapeutics. Most human proteins, however, lack small-molecule ligands, and entire protein classes are considered “undruggable” . Fragment-based ligand discovery (FBLD) can identify small-molecule probes for proteins that have proven difficult to target using high-throughput screening of complex compound libraries . Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-molecule probes , including those that can access regions of proteins that are difficult to access through binding affinity alone . In this manuscript, we report a quantitative analysis of cysteine-reactive small-molecule fragments screened against thousands of proteins. Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chemical probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins. Among the atypical ligand-protein interactions discovered were compounds that react preferentially with pro- (inactive) caspases. We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines versus primary human T-cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and −10. Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compounds that can illuminate protein functions in native biological systems.